Effect of race on outcome of orthotopic liver transplantation: A cohort study

Lancet

Volumn 359, Issue 9303, 2002, Pages 287-293

  Nair, Satheesh ^a   Eustace, Joseph ^b   Thuluvath, Paul J ^b  

^a OCHSNER MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; ASIAN; BLOOD GROUP; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; SEX; SURGICAL MORTALITY; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

EID: 0037176545     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)07494-9     Document Type: Article

References (39)

1. Racial disparities in renal transplant outcomes
2. Effect of race on renal transplant outcome
3. Causes of renal allograft loss in black vs white transplant recipients in the cyclosporine era
4. Determinants of chronic renal allograft rejection in cyclosporine-treated recipients
5. A multi-factor analysis of kidney graft outcomes at one and five years post-transplantation: 1996 UNOS Update
6. The effect of race on access and outcome in transplantation
7. Renal retransplantation at the University of Alabama at Birmingham: Incidence and outcome
8. Inferior outcome of two-haplotype matched renal transplants in blacks: Role of early rejection
9. UCLA liver transplantation: Analysis of immunological factors affecting outcome
10. Race: A critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation?
11. Liver transplantation in Black recipients: Pittsburgh
12. Report from Pitt-UNOS liver transplantation registry
13. Race and liver transplantation
14. Effect of race upon organ donation and recipient survival in liver transplantation
15. Long-term follow-up after liver transplantation for autoimmune hepatitis: Evidence of recurrence of primary disease
16. Predictors of patient and graft survival following liver transplantation for hepatitis C
17. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis
18. Poor outcome in patients with diabetes mellitus undergoing liver transplantation
19. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation
20. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation
21. Liver transplantation in the morbidly obese
22. Liver transplantation inpatients with severe obesity
23. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis
24. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience
25. Pretransplantation clinical status and outcome of emergency transplantation for acute liver failure
26. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group
27. Hepatitis B virus: The major etiology of hepatocellular carcinoma
28. Effect of donor age on graft outcome after liver transplantation
29. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome
30. Is donor age a risk factor for poor graft function after orthotopic liver transplantation?
31. Influence of donor age on graft survival after liver transplantation - United network for Organ sharing registry
32. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation
33. Donor age and outcome of liver transplantation
34. Effect of donor age and sex on the outcome of liver transplantation
35. Risk factors for primary dysfunction after liver transplantation - A multivariate analysis
36. Hepatitis B virus infection and hepatocellular carcinoma: Molecular genetics and clinical perspectives
37. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation
38. Liver transplantation in Asian patients with chronic hepatitis B
39. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin